CNTX

Dick Evan G.

Known title: SVP of R&DCIK: 0001862116

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 15, 2026

CNTX appears on Yahoo's recent strong negative rating lists. Yahoo listed Context Therapeutics in its strong negative rating lists for October 13 and October 15. The inclusion reflects recent analyst concerns about the company's outlook. The stock is currently trading with a low RSI and near its identified support level, which aligns with the negative sentiment.

this person other insiders at CNTX

Transaction History

CNTX▼ Sell—

We use analytics to understand how market-wall is used. No personal data is sold.